Real-world effectiveness and safety of secukinumab in giant cell arteritis: an Italian multicentre cohort study.
OBJECTIVE The objective of this study was to evaluate the real-world effectiveness and safety of secukinumab in giant cell arteritis (GCA) patients. METHODS This multicentre retrospective study included patients with GCA who received secukinumab at 14 Italian centres with at least 6 months of follow-up. Outcomes incl...